Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-DICLOFENAC | 0.1% | SOLUTION | Actual shortage | 2023-03-27 | 2023-09-27 | 188042 |
MINT-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Resolved | 2021-10-21 | 2023-04-01 | 147787 |
MINT-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169555 |
MINT-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-09-19 | 2023-03-13 | 169552 |
MINT-OSELTAMIVIR | 75MG | CAPSULE | Actual shortage | 2022-01-05 | 2023-01-03 | 152092 |
MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147790 |
MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147784 |
MINT-PIOGLITAZONE | 30MG | TABLET | Resolved | 2019-10-09 | 2023-01-03 | 95924 |
MINT-PIOGLITAZONE | 15MG | TABLET | Resolved | 2019-07-04 | 2023-01-03 | 88502 |
MINT-PIOGLITAZONE | 45MG | TABLET | Resolved | 2020-04-25 | 2023-01-03 | 113196 |
MINT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121279 |
MINT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121276 |
MINT-CIPROFLOX | 750MG | TABLET | Resolved | 2020-08-19 | 2022-06-06 | 122502 |
MINT-CIPROFLOX | 250MG | TABLET | Resolved | 2020-04-25 | 2022-06-06 | 113184 |
MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80792 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |